Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
40081
-
40082
Thermodynamic parameters.
Published 2025“…Consequently, tunnel reliability decreases. Specifically, with temperature increases of 2.6 °C and 4 °C, tunnel reliability decreases by approximately 4.5% and 6.3%, respectively, when considering insulation layer deterioration.…”
-
40083
-
40084
Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy
Published 2019“…Lower antibody and LPS levels among patients with initial PI-r ART suggest these regimens may more effectively suppress HIV and have a higher capacity to decrease the HIV antigenic component.…”
-
40085
-
40086
Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism
Published 2023“…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d<sup>9</sup> metalloradicals of the form [M(PR<sub>3</sub>)<sub>2</sub>]<sup>+</sup> (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr<sup>F</sup><sub>4</sub>]<sup>−</sup> (Ar<sup>F</sup> = 3,5-(CF<sub>3</sub>)<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) counterion. …”
-
40087
Stability and C–H Bond Activation Reactions of Palladium(I) and Platinum(I) Metalloradicals: Carbon-to-Metal H‑Atom Transfer and an Organometallic Radical Rebound Mechanism
Published 2023“…One-electron oxidation of palladium(0) and platinum(0) bis(phosphine) complexes enables isolation of a homologous series of linear d<sup>9</sup> metalloradicals of the form [M(PR<sub>3</sub>)<sub>2</sub>]<sup>+</sup> (M = Pd, Pt; R = <i>t</i>Bu, Ad), which are stable in 1,2-difluorobenzene (DFB) solution for >1 day at room temperature when partnered with the weakly coordinating [BAr<sup>F</sup><sub>4</sub>]<sup>−</sup> (Ar<sup>F</sup> = 3,5-(CF<sub>3</sub>)<sub>2</sub>C<sub>6</sub>H<sub>3</sub>) counterion. …”
-
40088
Distribution of the ΔNPP-to-ΔMAT ratio in relation to MAT and MAP under the current climate.
Published 2021“…<p>Results from (A) MIROC5 and (B) GFDL-CM3, based on the RCP2.6 scenario. …”
-
40089
-
40090
-
40091
Image2_The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes.JPEG
Published 2023“…Increased NAMPT expression in whole blood from VLBW neonates (day 5) significantly predicted BPD development. Compared to untreated LPS-challenged murine dams (gestational day 15), pups born to eNAMPT mAb-treated dams (gestational days 15/16) exhibited a > 3-fold improved survival, reduced neonate lung eNAMPT/cytokine levels, and reduced development and severity of BPD and pulmonary hypertension (PH) following postnatal exposure to 100% hyperoxia days 1–14. …”
-
40092
Image_2_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif
Published 2022“…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
-
40093
Image_1_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif
Published 2022“…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
-
40094
-
40095
-
40096
-
40097
-
40098
-
40099
-
40100